If you need more lookups,
subscriptions start at $34 USD/month.
Peter McCormack Location
Switzerland
Peter McCormack Work
Executive Director, and Head of Early Development Oncology Pharmacometrics Novartis @ (March 2023 - Present)
Senior Director of Pharmacometric Science @ (June 2020 - April 2023)
Principal Pharmacomatrician @ (January 2014 - September 2015)
Therapeutic Area Head of Pharmacometrics Oncology and Infection @ AstraZeneca (September 1997 - November 2013)
Peter McCormack Education
University of Kent, Oxford University, Manchester University
Biochemistry / Pharmacomterics / Mathematical Modelling and Risk assessment
Peter McCormack Skills
Pharmacokinetics
Drug Development
Oncology
Pharmaceutical Industry
Clinical Trials
Modelling and simulation
Pharmacometrics
Pharmacology
Clinical Pharmacology
Clinical Study Design
Monte carlo Simulation
PK/PD analysis
Translational Medicine
Regulatory Submissions
Science
Research
Peter McCormack Summary
Peter McCormack, based in Switzerland, is currently a Executive Director, and Head of Early Development Oncology Pharmacometrics Novartis at Novartis Oncology. Peter McCormack brings experience from previous roles at Novartis Oncology, Boehringer Ingelheim and AstraZeneca. Peter McCormack holds a Biochemistry / Pharmacomterics / Mathematical Modelling and Risk assessment @ University of Kent, Oxford University, Manchester University. With a robust skill set that includes Pharmacokinetics, Drug Development, Oncology, Pharmaceutical Industry, Clinical Trials and more. Peter McCormack has 2 emails on RocketReach.
Looking for a different Peter McCormack?
Find contact details for 700 million professionals.